Coloplast A/S CLPBF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.34% | 8.15% | 13.49% | 9.33% | 6.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.34% | 8.15% | 13.49% | 9.33% | 6.41% |
| Cost of Revenue | 15.07% | 11.12% | 19.34% | 10.60% | 1.02% |
| Gross Profit | 0.86% | 6.72% | 10.76% | 8.72% | 9.10% |
| SG&A Expenses | 8.60% | 8.06% | 12.71% | 9.94% | 3.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 64.37% | 5.27% | 8.80% | -30.87% | -572.47% |
| Total Operating Expenses | 12.90% | 10.08% | 15.98% | 10.77% | 1.31% |
| Operating Income | -12.46% | 3.06% | 6.85% | 5.47% | 20.73% |
| Income Before Tax | -9.73% | 42.87% | -192.63% | 10.42% | 3.12% |
| Income Tax Expenses | -65.02% | -21.51% | -152.35% | -40.73% | 150.13% |
| Earnings from Continuing Operations | 33.23% | 85.81% | -218.21% | 45.94% | -29.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.23% | 85.81% | -218.21% | 45.94% | -29.21% |
| EBIT | -12.46% | 3.06% | 6.85% | 5.47% | 20.73% |
| EBITDA | -5.22% | 3.85% | 7.74% | 6.82% | 19.53% |
| EPS Basic | 33.23% | 85.96% | -218.31% | 45.95% | -29.34% |
| Normalized Basic EPS | -16.76% | 35.97% | 25.65% | 8.24% | 29.11% |
| EPS Diluted | 33.30% | 86.00% | -218.31% | 46.05% | -29.33% |
| Normalized Diluted EPS | -16.76% | 35.97% | 25.65% | 8.24% | 29.11% |
| Average Basic Shares Outstanding | 0.00% | -0.09% | -0.09% | 0.00% | 0.18% |
| Average Diluted Shares Outstanding | 0.00% | -0.09% | -0.09% | 0.00% | 0.18% |
| Dividend Per Share | -1.70% | -- | 11.03% | -- | 12.55% |
| Payout Ratio | -- | -0.45% | -- | -0.21% | -- |